Nov 23 (Reuters) - Indivior PLC INDV.L :
* HEALTH CANADA APPROVES SUBLOCADE
* HEALTH CANADA HAS APPROVED SUBLOCADE (BUPRENORPHINE EXTENDED-RELEASE) INJECTION FOR SUBCUTANEOUS USE
* IN CANADA, SUBLOCADE WILL BE MARKETED BY INDIVIOR CANADA AND WILL BE AVAILABLE BY SECOND HALF OF 2019